Table 6.
Item | Treatment | UA, μmol/L | CRE, mmol/L | TAOC, U/mL | GSH, U/mL | SOD, U/mL | MDA, nmol/mL |
---|---|---|---|---|---|---|---|
Age | |||||||
60 d | CON | 10.1 | 16.0 | 11.0bc | 7.72ab | 123.2bc | 4.78ab |
LD | 14.1 | 21.7 | 11.2bc | 7.61bc | 127.8b | 4.55bc | |
MD | 11.6 | 17.9 | 11.2bc | 7.69ab | 124.8bc | 4.74ab | |
HD | 13.4 | 17.7 | 11.2bc | 7.80ab | 123.8bc | 4.77ab | |
90 d | CON | 14.9 | 19.4 | 12.3a | 6.94c | 144.1a | 3.88c |
LD | 11.6 | 20.1 | 12.1a | 7.06bc | 143.0a | 3.92c | |
MD | 8.27 | 26.7 | 11.7ab | 7.32bc | 131.6ab | 4.35bc | |
HD | 11.0 | 24.2 | 10.8c | 8.31a | 111.7c | 5.24a | |
Pooled SEM | 2.98 | 2.53 | 0.18 | 0.150 | 3.01 | 0.150 | |
Age | 60 d | 12.3 | 18.3b | 11.2 | 7.68 | 124.9 | 4.71 |
90 d | 11.4 | 22.6a | 11.7 | 7.41 | 132.6 | 4.34 | |
Pooled SEM | 1.51 | 1.27 | 0.09 | 0.070 | 1.53 | 0.080 | |
Treatment | CON | 12.5 | 17.7 | 11.7 | 7.33 | 133.7 | 4.33 |
LD | 12.8 | 20.9 | 11.6 | 7.34 | 135.4 | 4.23 | |
MD | 9.94 | 22.3 | 11.5 | 7.50 | 128.2 | 4.54 | |
HD | 12.3 | 20.9 | 11.0 | 8.00 | 117.8 | 5.01 | |
SEM | 2.13 | 1.79 | 0.13 | 0.110 | 2.16 | 0.110 | |
P-value | |||||||
Age | 0.69 | 0.02 | <0.01 | 0.01 | <0.01 | <0.01 | |
Treatment | 0.77 | 0.31 | <0.01 | <0.01 | <0.01 | <0.01 | |
Age × Treatment | 0.50 | 0.22 | <0.01 | <0.01 | <0.01 | <0.01 |
BHBA = β-hydroxybutyric acid; UA = uric acid; CRE = creatinine; TAOC = total antioxidant capacity; GSH = glutathione peroxidase; SOD = superoxide dismutase; MDA = malondialdehyde; CON = control; LD = low dose (3 g/d per animal BHBA); MD = medium dose (6 g/d per animal BHBA); HD = high dose (9 g/d per animal BHBA); SEM = the standard error of the means.
a,b,c Means with different superscripts within the same column differ significantly (P < 0.05).